Similarly, CM-272 showed potent antitumor effects when combined with proapoptotic agents (Bcl-2 inhibitor venetoclax, BCL-XL inhibitor A1331852, MCL-1 inhibitor S63845) in multiple tumor types [44]. This evidence concerns the gene BCL2L1 and neoplasm.